NCT07712302

Brief Summary

The goal of this interventional study is to learn if graded motor imagery with or without added neural mobilization can treat chemotherapy induced nerve related symptoms in lower limbs of cancer patients. The main questions it aims to answer are: \- Does graded motor imagery yields any added effects in relieving nerve related symptoms due to chemotherapy in lower limbs of cancer patients to the effects of nerve mobilization? Researchers will compare the effects of graded motor imagery as a standalone therapy (Group A) to the effects of graded motor imagery with nerve mobilization (Group B) Participants will take treatment sessions according to their allocated group, two sessions per week for six weeks.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 6, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 6, 2025

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

July 14, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 17, 2026

Completed
Last Updated

July 17, 2026

Status Verified

July 1, 2026

Enrollment Period

3 months

First QC Date

July 14, 2026

Last Update Submit

July 14, 2026

Conditions

Keywords

Cancer, Neural Mobilization, Graded Motor Imagery, Neuropathic pain, Nerve gliding, Chemotherapy Induced Peripheral Neuropathy, Sensory Ataxia

Outcome Measures

Primary Outcomes (1)

  • LANSS

    Leeds Assessment of Neuropathic Symptoms and Sign

    Baseline, week 3 (mid-intervention), week 6 (post intervention)

Secondary Outcomes (2)

  • Romberg Test

    Baseline, week 6 (post-intervention)

  • EORTC-QLQ-CIPN20

    Baseline, week 6 (post-intervention)

Study Arms (2)

Group A - Graded Motor Imagery

EXPERIMENTAL

Graded motor imagery sessions were provided twice a week for six weeks. Each GMI phase lasted for two weeks.

Other: Graded Motor Imagery

Group B - Grade Motor Imagey with Neural Mobilization

ACTIVE COMPARATOR

Graded motor imagery with neural mobilization sessions were provided twice a week for six weeks.

Other: Graded Motor ImageryOther: Neural Mobilization

Interventions

Graded motor imagery is a series of three steps. The first step, lateral recognition, includes graded left and right judgment exercises. The second step involves imagining the performance of movements and the third, and last step involves performing movements in front of a mirror.

Group A - Graded Motor ImageryGroup B - Grade Motor Imagey with Neural Mobilization

Nerve mobilization allows movement between structures of nervous system and its surrounding areas. It is used to mobilize the nervous system and maintain equilibrium inside the nervous system as well as in structures present in its surroundings.

Group B - Grade Motor Imagey with Neural Mobilization

Eligibility Criteria

Age31 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Both male and female
  • Age ranging from 31 to 65 years
  • Diagnosed cancer patients (stage 1 to 3, cancer of any kind)
  • Chemotherapy sessions (antineoplastic drugs) - at least 1 session
  • Presence of glove and stocking peripheral neuropathy
  • LANSS score greater than 12
  • Agreed to give complete follow-up

You may not qualify if:

  • Any co-morbid conditions that can cause peripheral neuropathy e.g. diabetes, chronic kidney failure
  • Any trauma history that can cause peripheral neuropathic symptoms
  • Pre-existing nerve entrapment syndromes
  • Diagnosed stage 4 cancer patients
  • Cancer patients taking palliative chemotherapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Faisalabad

Faisalābad, Punjab Province, 38000, Pakistan

Location

MeSH Terms

Conditions

NeoplasmsNeuralgiaAtaxia

Condition Hierarchy (Ancestors)

Peripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsDyskinesias

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Group A was given graded motor imagery Group B was given graded motor imagery with neural mobilization
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 14, 2026

First Posted

July 17, 2026

Study Start

March 1, 2025

Primary Completion

June 6, 2025

Study Completion

June 6, 2025

Last Updated

July 17, 2026

Record last verified: 2026-07

Locations